Abstract We describe three cases with visceral leishmaniasis (VL) associated with autoimmune manifestations. The patients presented with anemia, leukopenia, thrombocytopenia, renal involvement and low complement levels. Autoimmune features were present (antinuclear and anticardiolipin antibodies, VDRL, RF, positive direct CoombsÕ test), which subsided after therapy. Leishmaniasis should be taken into consideration in the differential diagnosis of autoimmune disorders.
Introduction
Leishmania parasites are obligate intracellular protozoa that produce clinical pictures ranging from localized, self-healing ulcers to systemic severe illness. The diseases caused by the parasites can be divided into cutaneous, mucocutaneous and visceral leishmaniasis (VL). Traditionally, diagnosis of this disease is based on demonstrating the parasites in various tissues, such as bone marrow or splenic aspirates.
Case reports

Case 1
A 37-year-old woman presented with a 1-month history of fatigue. Her medical history was notable for RaynaudÕs phenomenon only. The clinical examination was within normal limits. The hemoglobin level was 12 g/dl, the white cell count 3100/ll (35% polymorphonuclear, 59% lymphocytes, 6% monocytes). Platelet count was 75 000/ll. The erythrocyte sedimentation rate (ESR) was 50 mm/h, C-reactive protein (CRP) 80 mg/l, rheumatoid factor (RF) negative, and serum protein electrophoresis revealed polyclonal hypergammaglobulinemia. Liver and renal functions were normal. Urinalysis showed microscopic hematuria. Further investigations revealed positive antinuclear antibodies (ANA) (titer 1/320), with a fine-speckled pattern. The anti-DNA antibodies were negative, the C4 and C3 complement components were 23 and 74 mg/dl (normal values: 20-49 mg/dl and 52-125 mg/dl, respectively). Antibodies against Sm, SS-A, SS-B and RNP were absent. A viral screen was negative. She was started on prednisone 1 mg/kg daily on the presumptive diagnosis of SLE. Over the next 2 months the pancytopenia worsened. A bone marrow smear revealed phagocytosed Leishmania (Fig. 1) . Liposomal amphotericin B (iv) was started (5 mg/kg/day, days 1-5 and 10), with a very good response.
be 1500/ll (64% polymorphonuclear, 30% lymphocytes, 6% monocytes), hemoglobin 10 g/dl, and platelet count 45 000/ll. Relevant findings on the examination included an enlarged spleen, palpated 3 cm underneath the left costal border. Serology yielded a positive ANA (titer 1:320, speckled pattern). Urinalysis revealed 0.5 g protein/24 h. A diagnosis of probable SLE was given, based on the evidence of malar rash, hematological findings, proteinuria and positive ANA. She was treated with 36 mg methylprednisolone per day. The pyrexia and the splenomegaly persisted and she was admitted to our hospital after 1 month. A direct CoombsÕÕ test (DCT) was positive for IgG antibodies. The reticulocyte count was 2%, the ESR was 70 mm/h, CRP was 75 mg/l, RF was negative and serum protein electrophoresis revealed polyclonal hypergammaglobulinemia. ANA were positive at 1:320 dilution, with a speckled pattern, and the anti-dsDNA antibodies were negative. Serum C3 and C4 were normal. Antibodies against Sm, SS-A, SS-B, RNP and anticardiolipin antibodies were absent. Serologic tests for HIV, HCV, HbsAg, CMV, EBV and VDRL were negative. In a 24-h urine specimen the protein was 1 g. A bone marrow smear revealed phagocytosed Leishmania. Liposomal amphotericin B (iv) was started (5 mg/kg/day, days 1-5 and 10). Three months later she was well and the physical and laboratory examinations were within normal limits.
Case 3
A 50-year-old man presented with arthralgias, fatigue, weight loss and low-grade fever. Laboratory evaluation revealed hemoglobin 11.0 g/dl, white blood cells 3900/ ll with normal differential count, platelets 90 000/ll and ESR 93 mm/h. Physical examination revealed mild splenomegaly. Further laboratory work-up confirmed anemia, leukopenia and thrombocytopenia, increased CRP, moderate hypergammaglobulinemia and positive DCT (for IgG only), without other features of hemolysis. Renal, liver and thyroid function, as well as urine analysis, were within normal limits. Serological tests for viral hepatitis B and C, CMV, EBV and HIV were negative. Immunological tests revealed positive ANA at a titer of 1/160 with a fine-speckled pattern, RF at a titer of 1/40, IgM anticardiolipin antibodies 409 U (normal value <100U) and positive VDRL. Antibodies against dsDNA, Sm, SS-A, SS-B, RNP and b2GPI were negative. The C4 and C3 complement components were 9 and 136 mg/dl (normal values:10-40 mg/dl and 90-180 mg/dl, respectively). A diagnosis of probable SLE was considered, on the basis of the clinical presentation, hematological findings and positive ANA. No treatment was recommended at that stage. Two months later, he continued to experience high fevers, fatigue and weight loss. There was no evidence of active infection from respiratory, gastrointestinal and urinary tracts, or the central nervous system. A bone marrow smear had been done, but was considered not diagnostic of VL. He was treated with small doses of steroid without improvement. A repeated bone marrow examination disclosed the presence of Leishmania in the macrophages. Sodium antimony gluconate was administrated intramuscularly for 4 weeks, with excellent results.
Discussion
SLE is an autoimmune disease of unknown etiology affecting primarily young females, characterized by B-cell hyperactivity, expressed by the presence of many autoantibodies and immune complexes. The hematological abnormalities of SLE comprise anemia, leukopenia and thrombocytopenia. Anemia is found in approximately 50% of patients. The mechanisms involved in the pathogenesis of anemia in SLE are multiple and include the presence of antierythrocyte antibodies, humoral inhibitors of erythroid progenitor cells, and T-cell mediated suppression of erythropoiesis [1] . There is increasing evidence that erythropoiesis may be disturbed in SLE. It has been shown that bone marrow hypocellularity, increased fibrosis and bone marrow necrosis are findings in a number of SLE patients with peripheral cytopenias. These abnormalities suggest that the bone marrow is a target organ in SLE and may be disturbed through autoantibodies, T lymphocytes and changes in the cytokine network [2] . Renal involvement is clinically evident in 40%-85% of patients with SLE; it varies from isolated abnormalities of the urinary sediment to full-blown nephritic or nephrotic syndrome [3] . All our patients presented with features of SLE; however, these patients also had splenomegaly, high titers of CRP, severe neutropenia, and the direct CoombsÕCoombsÕ test was positive for IgG only. Splenomegaly is not a common sign of SLE and high titers of CRP are not a frequent laboratory finding, unless there is a concurrent infection or serositis [4] . Mild to moderate leukopenia is a feature in up to 50% of SLE patients at some point during the course of the disease, and may be due to neutropenia, lymphopenia, or a combination of the two [5] . In the cases we report, polymorphonuclear leukocyte numbers were very low, which is uncommon in SLE. Finally, a positive CoombsÕCoombsÕ test to IgG, without complement reactivity, is believed to be so rare in SLE that is suggestive of a non-SLE cause [5, 6] .
VL is characterized by fever, cytopenias and hypergammaglobulinemia, and may be associated with many immunological abnormalities. Cytopenias are mainly due to hypersplenism. According to Argov et al., anti-Sm, RNP, SS-A and SS-B antibodies were measured with an ELISA technique in 83%, 86%, 36% and 73% of patients with visceral leishmaniasis and 7%, 14%, 25% and 25% of patients with cutaneous leishmaniasis, respectively. In addition, the presence of cryoglobulins has been documented [7, 8, 9] . It seems that the appearance of autoantibodies to ribonucleoproteins in the sera of patients infected with Leishmania is not only due to simple polyclonal activation of lymphocytes, but it also results from molecular mimicry between leishmanial antigen and ribonucleoproteins [9] . Furthermore, the renal involvement is not infrequent. Proteinuria and/or microscopic hematuria or pyuria was observed in half of the patients. Of interest was the demonstration of tubulointerstitial involvement and mild proliferative glomerulonephritis in the renal histology [10, 11] . Microscopic hematuria of glomerular origin and proteinuria were demonstrated in our patients, indicating probable postinfectious glomerulonephritis triggered by immune complexes. The renal involvement reverted with the cure of the infection.
VL is endemic in 62 countries, with an estimated 500 000 new cases each year worldwide. Leishmania donovani is the principal cause of VL in the Indian subcontinent and East Africa, L. infantum in the Mediterranean basin, and L. chagasi in the New World. The last two species are identical. Human beings are the only known reservoir of L. donovani, whereas canines, especially domestic and stray dogs, provide the reservoir for L. infantum and L. chagasi. This difference has major consequences for control of the disease and the emergence and spread of drug resistance. There are approximately 30-100 subclinical cases for every overt case of VL. Risk factors include malnutrition, immunosuppressive drugs and HIV coinfection. Coinfected patients are difficult to diagnose, respond poorly to treatment and relapse frequently. All our patients had dogs. Alternatively, they were infected from subclinical cases [12] .
The diagnosis of VL is complex because its clinical features are shared by a host of other commonly occurring diseases, such as malaria, typhoid and tuberculosis; many of these diseases can be present along with VL (in cases of coinfection); sequestration of the parasite in the spleen, bone marrow or lymph nodes further complicates the issue.
Laboratory diagnosis of leishmaniasis can be made by the following: (I) demonstration of the parasite in relevant tissues by light microscopic examination of the stained specimen, in vitro cultures or animal inoculation; (ii) detection of parasite DNA in tissue samples; or (iii) immunodiagnosis by detection of parasite antigen in tissue, blood or urine samples, by detection of non-specific or specific antileishmanial antibodies (immunoglobulin), or by assay for Leishmania-specific cell-mediated immunity [13] .
Leishmania donovani is an intracellular parasite which is transmitted by the bite of phlebotomine sandflies. The parasite, in the form of flagellated promastigotes, attaches to macrophage receptors, is phagocytosed, is transformed into the non-flagellated amastigote form, and multiplies. After rupture of infected macrophages, amastigote parasites are phagocytosed by other macrophages [14] . In mice this antigen stimulation of macrophages leads to interleukin (IL)-12 production, which induces INF-c production and cytotoxic activity by natural killer and T cells, and can initiate the differentiation of Th1 cells from na T cells. This effective cellular immune response is required to kill the parasites and to confer resistance [15] . In humans, the parasitic stimulation may switch from a Th1 to a Th2 response, with the production of IL-4 and IL-10, which are associated with non-healing forms of leishmaniasis. An association between high antigen load and the development of Th2 responses has been previously described [16] . In fact, CD4 T cells from patients infected with Leishmania donovani, when cultured with specific antigen, do not secrete IL-2 and IFN-c, whereas the production of IL-4 and IL-10 is increased, which in turn activates B cells. Thus Leishmania donovani infection induces both nonspecific and specific antibody production, much of which is probably due to substances released from the parasite acting as B-cell mitogens [15] . However, the successful treatment in leishmaniasis requires the development of an effective Th1 immune response. The reduction of antigen levels with treatment may be necessary for IL-12 to switch an inappropriate Th2 to an effective Th1 response [16] .
In conclusion, VL may present with anemia, leukopenia, thrombocytopenia, a positive direct CoombsÕ test, renal involvement, low complement levels and the presence of autoantibodies, mimicking SLE. This must be taken into consideration when bone marrow in patients with an autoimmune profile and features of pancytopenia are examined. In addition, steroid treatment of SLE induces a state of immunosuppression, on the background of which VL can occur as an opportunistic infection [17] .
